Sleep Aids (Pharmacies) - Worldwide

Revenue in the Sleep Aids market is projected to reach US$3.89bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.35%, resulting in a market volume of US$4.36bn by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.50 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in worldwide is experiencing significant growth due to changing customer preferences and increasing demand for sleep aids.

Customer preferences: Customers around the world are increasingly prioritizing their sleep health and recognizing the importance of a good night's sleep. This shift in customer preferences is driving the demand for sleep aids in pharmacies. People are becoming more aware of the negative effects of sleep disorders and are seeking solutions to improve their sleep quality. As a result, they are turning to pharmacies to find over-the-counter sleep aids that can help them fall asleep faster and stay asleep longer.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the ingredients they consume and are opting for natural alternatives to traditional sleep aids. This trend is driven by the perception that natural sleep aids have fewer side effects and are safer for long-term use. As a result, pharmacies are expanding their offerings to include a wider range of natural sleep aids to cater to this growing demand. Another trend in the market is the increasing availability of sleep aids in different forms. Traditionally, sleep aids were primarily available in pill or capsule form. However, pharmacies are now offering sleep aids in various formats such as gummies, sprays, and drinks. This diversification of product offerings allows customers to choose the format that best suits their preferences and needs.

Local special circumstances: In some countries, there are specific regulations and restrictions on the sale of sleep aids in pharmacies. For example, in certain regions, sleep aids may only be available with a prescription from a healthcare professional. This local special circumstance can impact the availability and accessibility of sleep aids in pharmacies, leading to variations in market growth across different countries.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market is also influenced by underlying macroeconomic factors. Economic growth and rising disposable incomes play a significant role in driving the demand for sleep aids. As economies grow, people have more purchasing power and are willing to spend on products that can improve their sleep quality. Additionally, increasing urbanization and changing lifestyles, such as longer working hours and higher stress levels, contribute to the rising demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in worldwide is witnessing growth due to changing customer preferences, including a focus on sleep health and a preference for natural alternatives. The market is also influenced by trends such as the availability of sleep aids in different forms. However, local special circumstances and underlying macroeconomic factors can impact the growth of the market in different countries.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.